29 June 2022 ReCode Therapeutics to Expand Next-Generation Delivery Platform and Diversify Genetic Medicines Pipeline with Oversubscribed Series B Financing Totaling $200M read more
15 June 2022 Affini-T Therapeutics & Metagenomi Announce Next-Generation Gene Editing Partnership to Advance Cell Therapies for Solid Tumor Patients read more
16 May 2022 Arie Belldegrun, M.D. Named one of Fierce Pharma’s Most Influential People in Biopharma read more
22 March 2022 Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations read more
21 March 2022 Volastra Therapeutics Announces Drug Discovery Collaboration With Bristol Myers Squibb read more
